2.11
前日終値:
$2.15
開ける:
$1.99
24時間の取引高:
914.64K
Relative Volume:
0.24
時価総額:
$4.19M
収益:
-
当期純損益:
$-8.22M
株価収益率:
-0.0772
EPS:
-27.3467
ネットキャッシュフロー:
$-8.01M
1週間 パフォーマンス:
-16.27%
1か月 パフォーマンス:
+15.93%
6か月 パフォーマンス:
-63.87%
1年 パフォーマンス:
-87.07%
Enveric Biosciences Inc Stock (ENVB) Company Profile
名前
Enveric Biosciences Inc
セクター
電話
(617) 444-8400
住所
245 FIRST STREET RIVERVIEW II 18TH FLOOR, CAMBRIDGE
Compare ENVB vs VRTX, REGN, ARGX, ALNY, RVMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
ENVB
Enveric Biosciences Inc
|
2.11 | 4.27M | 0 | -8.22M | -8.01M | -27.35 |
|
VRTX
Vertex Pharmaceuticals Inc
|
434.31 | 110.81B | 12.34B | 4.34B | 3.71B | 16.87 |
|
REGN
Regeneron Pharmaceuticals Inc
|
630.30 | 66.02B | 14.92B | 4.42B | 3.79B | 41.04 |
|
ARGX
Argen X Se Adr
|
797.77 | 48.27B | 4.16B | 1.29B | 734.26M | 19.58 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
294.30 | 38.22B | 4.29B | 577.22M | 641.34M | 4.2086 |
|
RVMD
Revolution Medicines Inc
|
147.30 | 30.69B | 742.00K | -1.37B | -1.07B | -7.0731 |
Enveric Biosciences Inc (ENVB) 最新ニュース
Enveric Biosciences Reports Positive Preclinical Results from Phototoxicity Analysis for Lead Neuroplastogen Candidate EB-003 - Investing News Network
Enveric Biosciences (ENVB) Achieves Key Milestone in Neuropsychi - GuruFocus
Enveric Biosciences Reports Financial Results and Provides Corporate Update for First Quarter 2026 - BioSpace
Enveric Biosciences Inc (ENVB) Stock Price, Quote, News & History - Benzinga
Enveric Biosciences (ENVB) affiliates report 158,732 warrants; Easton 161,232 - Stock Titan
Enveric (ENVB) Secures $13.9 Million in Private Placement Fundin - GuruFocus
Enveric (ENVB) Advances in Mental Health Therapeutics Developmen - GuruFocus
Enveric Biosciences Reports Q1 2026 Results, Advances Non-Hallucinogenic Antidepressant EB-003 Toward Clinical Trials - Minichart
Enveric Biosciences Releases Q1 2026 Financial Results - AlphaStreet
Enveric Biosciences (NASDAQ: ENVB) posts Q1 2026 loss and flags going concern risk - Stock Titan
Enveric Biosciences (ENVB) advances EB-003 and boosts cash in Q1 2026 - Stock Titan
What's going on with Enveric Biosciences stock on Friday? - MSN
Enveric Biosciences Expands IP Portfolio with New U.S. Patent Issued for Methods of Treating Psychiatric Disorders - Investing News Network
Enveric highlights preclinical PTSD data amid rising focus on mental health therapies - MSN
Enveric Biosciences receives patent for psilocybin derivatives By Investing.com - Investing.com Canada
Enveric Biosciences (ENVB) Expands Patent Portfolio with New Psi - GuruFocus
Enveric Biosciences Stock Short Interest Rises to 45.7% - Moomoo
TradingKey - TradingKey
MSN Money - MSN
Enveric Biosciences Inc. (ENVB) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
ENVB Stock Price, Quote & Chart | ENVERIC BIOSCIENCES INC (NASDAQ:ENVB) - ChartMill
Enveric Biosciences Highlights Positive Results for EB-003 in PTSD Preclinical Model - Investing News Network
Enveric Biosciences IncReports positive preclinical results for EB-003 in PTSD model - marketscreener.com
Enveric Highlights Preclinical PTSD Data Amid Rising Focus On Mental Health TherapiesEnveric Bioscienc - Benzinga
Enveric Biosciences surges over 90%, other psychedelic stocks soar in Monday pre-market: What's going on? - MSN
Enveric Biosciences Corrects Reverse Stock Split Proxy Disclosure - TipRanks
Enveric Biosciences (ENVB) clarifies 1‑for‑15 max reverse split in 2026 proxy - Stock Titan
Enveric Biosciences | EFFECT: Others - Moomoo
Enveric Biosciences (NASDAQ: ENVB) files resale prospectus for 6.82M shares - Stock Titan
Lakewood-Amedex appoints Enveric CEO to board of directors - Investing.com UK
Lakewood-Amedex Biotherapeutics Appoints Joseph Tucker, Ph.D., to Board of Directors - Investing News Network
Lakewood-Amedex appoints Enveric CEO to board of directors By Investing.com - Investing.com Nigeria
Enveric Biosciences Inc (ENVB) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):